Rifabutin but not clarithromycin prevents cryptosporidiosis in persons with advanced HIV infection

AIDS

Volumn 14, Issue 18, 2000, Pages 2889-2893

  Fichtenbaum, Carl J ^a   Zackin, Robert ^b   Feinberg, Judith ^a   Benson, Constance ^c   Griffiths, Jeffrey K ^d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clarithromycin; Cryptosporidosis; HIV infection; Macrolides; Rifabutin

Indexed keywords

CLARITHROMYCIN; RIFABUTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYPTOSPORIDIOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM INTRACELLULARE AVIUM; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; CHILD; CLARITHROMYCIN; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; RIFABUTIN;

EID: 0034518412     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200012220-00010     Document Type: Article

References (18)

1. Acquired immuno-deficiency with intestinal cryptosporidiosis: Possible transmission by Haitian Whole Blood
2. Cryptosporidium infection and CD4 counts
3. Epidemiology of cryptosporidiosis among persons with acquired immunodeficiency syndrome in Los Angeles County
4. Natural history of opportunistic disease in an HIV-infected urban clinical cohort
5. Treatment of HIV-1-associated microsporidiosis and cryptosporidiosis with combination antiretroviral therapy
6. Improvement of chronic diarrhoea in patients with advanced HIV-1 infection during potent antiretroviral therapy
7. Human cryptosporidiosis: Epidemiology, transmission, clinical disease, treatment, and diagnosis
8. Impact of antiretroviral therapy (ART) on cryptosporidiosis outcome and factors of clinical resistance
9. Anti-cryptosporidial drug activity screened with an immunosuppressed rat model
10. Treatment of acute and chronic Cryptosporidium parvum infections in mice using clarithromycin and 14-OH clarithromycin
11. Anti-cryptosporidial activity of macrolides immuno-suppressed rats
12. Chemotherapeutic effect of azithromycin and lasalocid on cryptosporidium infection in mice
13. A comparison of anticryptosporidial activity of paromomycin with that of other aminoglycosides and azithromycin in immunosuppressed rats
14. Activity of azithromycin against Cryptosporidia in immunosuppressed rats
15. Azithromycin therapy for Cryptosporidium parvum infection in four children infected with human immunodeficiency virus
16. Possible effectiveness of clarithromycin and rifabutin for cryptosporidium chemoprophylaxis in HIV disease
17. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS; a randomized, double-blind, placebo-controlled trial
18. A randomized, double-blind trial of valacyclovir prophylaxis for cytomegalovirus disease in patients with advanced humanimmunodeficiency virus infection